Tag Archives: health professionals
Warfarin

Zydus Pharmaceuticals Warfarin 2 mg Tablets Recalled due to Oversized Tablets

The US FDA informs pharmacy, health professionals and patients that one lot of Zydus Pharmaceuticals Warfarin 2 mg tablets is recalled because some tablets have been found to be oversized and patients may be at risk of bleeding.  Background of Warfarin 2 mg Tablets Warfarin 2 mg tablets, by Zydus Pharmaceuticals, are used as prophylaxis [...]

Read more
Methotrexate Injection Sandoz

Methotrexate Sodium USP Injectable Vials by Sandoz Recalled due to the Presence of Particulate Matter

Pharmacy, health professionals and patients are informed by the FDA that two lots of Methotrexate Sodium USP Injectable 25 mg/mL, 40 mL Vials by Sandoz are recalled due to the presence of particulate matter in vials. Background of Methotrexate Sodium USP Injectable Vials Methotrexate is used to treat severe psoriasis, neoplastic diseases, and rheumatoid arthritis, [...]

Read more
FreeStyle Insulinx

FreeStyle InsuLinx Blood Glucose Meters Recalled (Class I) due to Risk of Incorrect Test Result

The FDA informs risk managers, health professionals and patients that FreeStyle InsuLinx blood glucose meters are recalled because there is a risk of incorrect test results. Background of FreeStyle InsuLinx Blood Glucose Meters FreeStyle InsuLinx blood glucose meters, by Abbott Diabetes Care, are used to monitor blood sugar levels. FDA Alert on FreeStyle InsuLinx Blood [...]

Read more
Pentec Compounded Prescription Therapies Recalled due to Lack of Sterility Assurance

Pentec Compounded Prescription Therapies Recalled due to Lack of Sterility Assurance

The FDA informs pharmacy, health professionals and patients that Compounded Prescription Therapies by Pentec are recalled due to lack of sterility assurance that may pose an increased risk of infection. Background of Pentec Compounded Prescription Therapies Compounded prescription therapies, by Pentec Health, are renal therapies supplied to renal dialysis centers and to patients. FDA Alert [...]

Read more
Samsca (Tolvaptan): Limited Duration and Usage Due To Possible Liver Injury

Samsca (Tolvaptan): Limited Duration and Usage Due To Possible Liver Injury

Pharmacy, health professionals and patients are informed that the FDA limits duration and usage of Samsca (Tolvaptan) due to possible liver injury that may lead to organ transplant or death. Background of Samsca (Tolvaptan) Samsca, by Otsuka America Pharmaceutical Inc., is a selective vasopressin V2-receptor antagonist used to treat clinically significant hypervolemic and euvolemic hyponatremia. [...]

Read more